empagliflozin 5 MG / metFORMIN HCl 1000 MG 24HR Extended Release Oral Tablet
- RxCUI
- 1862700
- RxNorm name
- empagliflozin 5 MG / metFORMIN HCl 1000 MG 24HR Extended Release Oral Tablet
- Display name
- empagliflozin 5 MG / metFORMIN HCl 1000 MG 24HR Extended Release Oral Tablet
- Full name
- empagliflozin 5 MG / metFORMIN HCl 1000 MG 24HR Extended Release Oral Tablet
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:05
UNII Substances#
No records found.
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Synjardy XR | EMPAGLIFLOZIN, METFORMIN HYDROCHLORIDE | Boehringer Ingelheim Pharmaceuticals, Inc. | 8006ba29-ee3a-f852-a9bb-c8ec9b41cf66 | 2026-01-20 | Boxed warning, Warnings, Adverse reactions | 1862700 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 8006ba29-ee3a-f852-a9bb-c8ec9b41cf66 | empagliflozin 5 MG / metFORMIN HCl 1000 MG 24HR Extended Release Oral Tablet | PSN | 17 | These highlights do not include all the information needed to use SYNJARDY and SYNJARDY XR safely and effectively. See full prescribing information for SYNJARDY and SYNJARDY XR. SYNJARDY ® (empagliflozin and metformin hydrochloride tablets), for oral use SYNJARDY ® XR (empagliflozin and metformin hydrochloride extended-release tablets), for oral use Initial U.S. Approval: 2015 | 20260120 |
| 8006ba29-ee3a-f852-a9bb-c8ec9b41cf66 | 24 HR empagliflozin 5 MG / metformin hydrochloride 1000 MG Extended Release Oral Tablet | SCD | 17 | These highlights do not include all the information needed to use SYNJARDY and SYNJARDY XR safely and effectively. See full prescribing information for SYNJARDY and SYNJARDY XR. SYNJARDY ® (empagliflozin and metformin hydrochloride tablets), for oral use SYNJARDY ® XR (empagliflozin and metformin hydrochloride extended-release tablets), for oral use Initial U.S. Approval: 2015 | 20260120 |
| 8006ba29-ee3a-f852-a9bb-c8ec9b41cf66 | empagliflozin 5 MG / metformin HCl 1000 MG 24HR Extended Release Oral Tablet | SY | 17 | These highlights do not include all the information needed to use SYNJARDY and SYNJARDY XR safely and effectively. See full prescribing information for SYNJARDY and SYNJARDY XR. SYNJARDY ® (empagliflozin and metformin hydrochloride tablets), for oral use SYNJARDY ® XR (empagliflozin and metformin hydrochloride extended-release tablets), for oral use Initial U.S. Approval: 2015 | 20260120 |